Does the Difference in Leukocyte Concentration of PRP Affect the Short-Term Follow-Up Results in Cases Diagnosed with Early Stage Knee Osteoarthritis?
- Resource Type
- Authors
- Adnan Kara; Mehmet Isyar; Özgür Korkmaz; Ismail Oltulu; Ahmet Murat Bülbül; Mahir Mahirogullari
- Source
- Serbian Journal of Experimental and Clinical Research, Vol 21, Iss 4, Pp 325-331 (2020)
- Subject
- 030203 arthritis & rheumatology
030222 orthopedics
medicine.medical_specialty
business.industry
Follow up results
General Medicine
Osteoarthritis
knee osteoarthritisspleen
Affect (psychology)
medicine.disease
Term (time)
nervous system diseases
03 medical and health sciences
0302 clinical medicine
Internal medicine
medicine
Medicine
Stage (cooking)
business
leukocyte
platelet rich plasma
- Language
- English
- ISSN
- 1820-8665
This prospective study was conducted for the clinical evaluation of pain severity and knee functionality following PRP injections with different leukocyte (WBC) concentrations applied to cases diagnosed with knee osteoarthritis. A total of 109 patients were included in the study. According to the leukocyte content the PRP injections were prepared as low-leukocyte content PRP (P-PRP) and high concentration leukocyte content PRP (L-PRP). Patients were divided into 2 groups. Group 1 (n=44) received low-leukocyte content PRP and Group II (n = 65) received high-leukocyte content PRP. The patients were evaluated clinically with Visual Analog Scale (VAS) and Knee Society Score (KSS). The changes in the PLT levels of the L-PRP group after the procedure compared to the levels prior to the procedure were found to be statistically significantly greater than the changes in the PPRP group. The mean VAS score of all the cases before treatment was 9.05±0.91 and this score decreased to 3.71±1.46 within 12 months. The increases in the mean Knee Society Score (KSS) values were determined as 16.92±1.97 within 6 months and 16.89±2.97 within 12 months in the P-PRP group and 19.71±1.24 within 6 months and 19.86±0.42 within 12 months in the L-PRP group. The most important aspect of this study is that, in contrast to many other studies, the results continued after the 6th month and were reported to be good in the 12th month. It was also recorded that L-PRP was clinically superior to P-PRP in the treatment of early stage knee osteoarthritis.